In the other 10 patient samples (poorly differentiated squamous cell carcinoma), decreased GSK-3β and p-GSK-3βSer9 protein expression levels were observed, but no significant changes in p-GSK-3βTyr216 levels were identified (Fig. 2). Here, GSK3B is linked to squamous cell carcinoma.